Bildkälla: Stockfoto

Isofol Medical Q2’21: Funding Completed in Run-Up to Crucial Read-out - Redeye

Redeye views the Q2 update on the ongoing AGENT trial as positive. We have adjusted our valuation range to account for the completed share issues.

Redeye views the Q2 update on the ongoing AGENT trial as positive. We have adjusted our valuation range to account for the completed share issues.
Börsvärldens nyhetsbrev
ANNONSER